HA activation of CD44 is known to exert significant effects on cancer metastasis of a variety of tumor types including lung adenocarcinoma, in part, by potentiating the activation of PI3K, AKT, and nuclear localization of NFκB [18,19,21,23,74,75]. This evidence concerns the gene CD44 and neoplasm.